Skip to main content
Premium Trial:

Request an Annual Quote

Evogene Raises Another $1.5M in Second Closing of Initial Placement

NEW YORK, Feb. 24 (GenomeWeb News) - Evogene has raised another $1.5 million in a second closing of its first private placement, the company said today.


The second closing brings the total amount of the first round to $3.5 million, after the first closing in March of 2003.


Evogene, based in Rehovot, Israel, combines predictive computational biology and plant genomics with classical breeding technologies to generate improved crops. The company was spun out of Compugen in 2002.


The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more